NCT07202195Recruiting
At Home Use of Stimulation Suits for Managing MS Symptoms
Home-Based Neuromodulation Suits for Reducing Spasticity and Ataxia in Multiple Sclerosis: A Multi-center RCT
Source: ClinicalTrials.gov · Last updated 8 Oct 2026
Brief summary (registry, in English)
This study is being carried out at Multiple Sclerosis (MS) centers to evaluate whether a full-body stimulation suit at home can help people with Multiple Sclerosis (pwMS) reduce symptoms like spasticity (muscle stiffness) and ataxia (poor coordination), and improve daily functioning. Can pwMS who experience spasticity or ataxia benefit from using a stimulation suit for 6 weeks? Researchers will compare two groups: an intervention group (who will use the suit) and a control group (who will not use the suit). Participants in the intervention group will: * Wear the suit for 6 weeks in total every day or every other day (1 week during their MS center admission and 5 weeks at home). * Receive their usual care in addition to wearing the suit. * Undergo clinical tests at the MS center after 1 week and 6 weeks of stimulation. Participants in the control group will: * Receive their usual care. * Undergo clincial tests at the same time points as the other group.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 70 (estimated)
- First submitted
- 25 Aug 2025
- Start date
- 16 Mar 2026
- Primary completion date
- Sept 2027
- Lead sponsor
- Daphne Kos
- Diseases
- Multiple sclerosis
- NCT number
- NCT07202195
What you commit to
- Study type: Interventional
- Planned participants: 70
- From 16 Mar 2026 to the primary completion date, Sept 2027
- 2 sites in 2 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Change in disease modifying treatment within the last 3 months
- Skin eruptions and/or skin areas in the stimulation zone that are swollen, infected or inflamed.
Other
- Implanted devices (like pacemaker, Baclofen pump, neurostimulator, defibrillator, shunts, ECG equipment, electronic life support, high frequency operation equipment )
- Use of Botuline Toxine A within the last 3months
- Recent relapse within the last 3 months
- Acute musculoskeletal problems that hinder the test performance,
- Pregnancy
- Sizes bigger than 3XL (triple eXtra Large)
Who the study is looking for
- Eligible participants must have ataxia or spasticity alongside impairments in upper or lower extremity physical function. MAS score ≥ 1 will be used as an inclusion criterion to determine the presence of spasticity. SARA score ≥ 4 will be used as an inclusion criterion to determine the presence of ataxia. Note: one of the two criteria (MAS score or SARA score) must be fulfilled for a pwMS to be eligible.
- The patient must have the cognitive abilities to understand instructions and to be able to complete the questionnaires adequately
- Diagnosis of multiple sclerosis.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Nationaal MS Center Melsbroek Coordinator of this site? Confirm its status | Steenokkerzeel | Belgium | Recruiting |
| The Danish MS Hospitals Coordinator of this site? Confirm its status | Ry | Denmark | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.